PMC:7212949 / 6502-7028 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T25","span":{"begin":223,"end":227},"obj":"Body_part"},{"id":"T26","span":{"begin":228,"end":234},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"fma_id","subj":"T25","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"Key study findings and message • 23.2% ICU admission, at day 6 (mean)\n• 13.8% mechanical ventilation rate\n• 3.6% crude mortality rate\n• ICU patients more likely to be of older age (P = 0.009) Severe immunological damage to lung tissue causes clinical features • Fever most common and earliest symptom\n• 23% mechanical ventilation rate • 83.33% of patients with GGO developed ARDS\n• 20% mechanical ventilation\n• 17% ICU admission\n• Recurrence of fever (univariate) and age (multivariate) risk factors for ARDS and ICU admission"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T21","span":{"begin":223,"end":227},"obj":"Body_part"},{"id":"T22","span":{"begin":228,"end":234},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"uberon_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A22","pred":"uberon_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Key study findings and message • 23.2% ICU admission, at day 6 (mean)\n• 13.8% mechanical ventilation rate\n• 3.6% crude mortality rate\n• ICU patients more likely to be of older age (P = 0.009) Severe immunological damage to lung tissue causes clinical features • Fever most common and earliest symptom\n• 23% mechanical ventilation rate • 83.33% of patients with GGO developed ARDS\n• 20% mechanical ventilation\n• 17% ICU admission\n• Recurrence of fever (univariate) and age (multivariate) risk factors for ARDS and ICU admission"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T41","span":{"begin":375,"end":379},"obj":"Disease"},{"id":"T42","span":{"begin":504,"end":508},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Key study findings and message • 23.2% ICU admission, at day 6 (mean)\n• 13.8% mechanical ventilation rate\n• 3.6% crude mortality rate\n• ICU patients more likely to be of older age (P = 0.009) Severe immunological damage to lung tissue causes clinical features • Fever most common and earliest symptom\n• 23% mechanical ventilation rate • 83.33% of patients with GGO developed ARDS\n• 20% mechanical ventilation\n• 17% ICU admission\n• Recurrence of fever (univariate) and age (multivariate) risk factors for ARDS and ICU admission"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T44","span":{"begin":223,"end":227},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T45","span":{"begin":223,"end":227},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Key study findings and message • 23.2% ICU admission, at day 6 (mean)\n• 13.8% mechanical ventilation rate\n• 3.6% crude mortality rate\n• ICU patients more likely to be of older age (P = 0.009) Severe immunological damage to lung tissue causes clinical features • Fever most common and earliest symptom\n• 23% mechanical ventilation rate • 83.33% of patients with GGO developed ARDS\n• 20% mechanical ventilation\n• 17% ICU admission\n• Recurrence of fever (univariate) and age (multivariate) risk factors for ARDS and ICU admission"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T32","span":{"begin":262,"end":267},"obj":"Phenotype"},{"id":"T33","span":{"begin":431,"end":450},"obj":"Phenotype"}],"attributes":[{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0001954"}],"text":"Key study findings and message • 23.2% ICU admission, at day 6 (mean)\n• 13.8% mechanical ventilation rate\n• 3.6% crude mortality rate\n• ICU patients more likely to be of older age (P = 0.009) Severe immunological damage to lung tissue causes clinical features • Fever most common and earliest symptom\n• 23% mechanical ventilation rate • 83.33% of patients with GGO developed ARDS\n• 20% mechanical ventilation\n• 17% ICU admission\n• Recurrence of fever (univariate) and age (multivariate) risk factors for ARDS and ICU admission"}

{"project":"LitCovid-sentences","denotations":[{"id":"T87","span":{"begin":0,"end":69},"obj":"Sentence"},{"id":"T88","span":{"begin":70,"end":105},"obj":"Sentence"},{"id":"T89","span":{"begin":106,"end":133},"obj":"Sentence"},{"id":"T90","span":{"begin":134,"end":300},"obj":"Sentence"},{"id":"T91","span":{"begin":301,"end":379},"obj":"Sentence"},{"id":"T92","span":{"begin":380,"end":408},"obj":"Sentence"},{"id":"T93","span":{"begin":409,"end":428},"obj":"Sentence"},{"id":"T94","span":{"begin":429,"end":526},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Key study findings and message • 23.2% ICU admission, at day 6 (mean)\n• 13.8% mechanical ventilation rate\n• 3.6% crude mortality rate\n• ICU patients more likely to be of older age (P = 0.009) Severe immunological damage to lung tissue causes clinical features • Fever most common and earliest symptom\n• 23% mechanical ventilation rate • 83.33% of patients with GGO developed ARDS\n• 20% mechanical ventilation\n• 17% ICU admission\n• Recurrence of fever (univariate) and age (multivariate) risk factors for ARDS and ICU admission"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T99","span":{"begin":23,"end":30},"obj":"CHEBI:33695;CHEBI:33695"},{"id":"T100","span":{"begin":223,"end":227},"obj":"UBERON:0002048"},{"id":"T101","span":{"begin":228,"end":234},"obj":"UBERON:0000479"},{"id":"T509","span":{"begin":8,"end":18},"obj":"UBERON:0002349"},{"id":"T510","span":{"begin":35,"end":40},"obj":"NCBITaxon:10239"},{"id":"T511","span":{"begin":41,"end":51},"obj":"UBERON:0002349"},{"id":"T512","span":{"begin":141,"end":151},"obj":"UBERON:0002349"},{"id":"T513","span":{"begin":196,"end":204},"obj":"UBERON:0000948"},{"id":"T514","span":{"begin":326,"end":333},"obj":"UBERON:0000948"},{"id":"T515","span":{"begin":369,"end":372},"obj":"SO:0000694"},{"id":"T516","span":{"begin":377,"end":387},"obj":"CHEBI:16737;CHEBI:16737"},{"id":"T517","span":{"begin":410,"end":412},"obj":"UBERON:0000029"},{"id":"T518","span":{"begin":427,"end":434},"obj":"UBERON:0000948"},{"id":"T519","span":{"begin":493,"end":498},"obj":"GO:0016265"}],"text":"Key study findings and message • 23.2% ICU admission, at day 6 (mean)\n• 13.8% mechanical ventilation rate\n• 3.6% crude mortality rate\n• ICU patients more likely to be of older age (P = 0.009) Severe immunological damage to lung tissue causes clinical features • Fever most common and earliest symptom\n• 23% mechanical ventilation rate • 83.33% of patients with GGO developed ARDS\n• 20% mechanical ventilation\n• 17% ICU admission\n• Recurrence of fever (univariate) and age (multivariate) risk factors for ARDS and ICU admission"}